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RESUMO
ABSTRACT
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The methanolic extract of leaves from Byrsonima crassa,
a Brazilian medicinal plant, was analyzed by CC and
HPLC. Four constituents were isolated and identified
as quercetin, methyl gallate, (-)-epigallocatechin gallate
and quercetin-3-O-(2”-galloyl)-a-L-arabinopyranoside.
The methanolic and hydromethanolic extract, as well
as fractions, were evaluated regarding their possible
antimicrobial activity using in vitro methods. Results
showed that both extracts and fractions exhibited
significant antimicrobial activity against all tested
strains.
Keywords: Byrsonima crassa, antimicrobial activity,
Malpighiaceae.
Byrsonima crassa Niedenzu (IK):
atividade antimicrobiana e estudo químico
O extrato metanólico de Byrsonima crassa, uma planta
medicinal brasileira, foi analisado por CC e HPLC.
Foram isolados e identificados quatro constituintes como
quercetina, galato de metila, (-)-epigalocatequina galato
e quercetina-3-O-(2”-galoil)-a-L-arabinopiranosídeo.
Os extratos metanólico e hidrometanólico e frações
foram submetidos a ensaios para avaliação da possível
atividade antimicrobiana in vitro usando métodos de
difusão e diluição. Todos os extratos e frações analisados
exibiram uma significante atividade antimicrobiana
frente a todas as linhagens testadas.
Palavras-chave: Byrsonima crassa, atividade
antimicrobiana, Malpighiaceae.
INTRODUCTION
Byrsonima crassa Niedenzu (IK) is a tree native to
savannah-like areas in Brazil, which is popularly known
as ‘murici-cascudo’ or ‘murici-vermelho’. The bark and
leaves are used in Brazilian popular medicine to treat
diarrhea, ulcers, gastritis and even cutaneous problems
(Silva et al., 2001; Lopez et al., 2001).
A small number of Byrsonima species have been
evaluated chemically. Such phytochemical studies have led
to the isolation of flavonoids, triterpenes, steroids, non-
protein amino acids, sulphonoglycolipids and
proanthocyanidins (Rastrelli et al., 1997; Bejar et al., 1995;
Geiss et al., 1995; Amarquaye et al., 1994; Gottlieb et al.,
1975; Mendes et al., 1999). Phytochemical investigation
of the MeOH extract from the leaves of Byrsonima crassa
have led to the isolation of catechins and flavonoid
glycosides (Sannomiya et al., 2004; 2005).
Antimicrobial tests performed in vitro have shown
that the extract B. verbascifolia was able to inhibit the
growth of Streptococcus faecalis, Mycobacterium phlei,
Staphylococcus aureus and Bacillus subtilis (Martínez-
Vásquez et al., 1999; Lopez et al., 2001). Martínez-Vásquez
et al. (1999) reported the antibacterial activities of B.
crassifolia extracts against Klebsiella pneumoniae,
Pseudomonas aeruginosa, Salmonella typhi, Shigella
flexneri, Staphylococcus aureus, S. epididermis,
Streptococcus pneumoniae and Micrococcus luteus.
Despite its popular use as a medicinal plant, there
are no data about the antimicrobial effect of leaf extract of
this species. The present study was conducted to evaluate
the antimicrobial activity of B. crassa leaf extracts by the
disc-diffusion method.  We also proceeded to the isolation
and identification of some minor compounds in the leaf
extract.
MATERIAL AND METHODS
Microorganisms: Eight microbial species were used and
were taken from international collections. They included
the bacteria: Bacillus subtilis (ATCC 9372), Bacillus cereus
(ATCC 14579), Shigella sp. (IAL 1578), Staphylococcus
epidermidis (ATCC 12226), Proteus mirabilis (CDC 305),
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Salmonella sp. (ATCC 19196), Enterococcus faecalis
(ATCC 29212), and the yeast Candida albicans (ATCC
10231).
Plant material:Leaves of Byrsonima crassa Niedenzu (IK)
were collected at Porto Nacional, Tocantins State, Brazil
and authenticated by Eduardo Ribeiro dos Santos. A
voucher specimen (n° 3377) was deposited at the
Herbarium of Tocantins University.
Extract preparation: The air-dried leaves of B. crassa
(2.0 kg) were grounded and extracted three times with each
solvent in the  each solvent in the series chloroform,
methanol and finally methanol/water 80:20 (v/v), at room
temperature (48 h per solvent). The extracts for each solvent
were combined and evaporated in vacuo to yield three
fractions, designated ECHCl3 (53.8 g), EMeOH (158.3 g)
and EMeOH 80% extracts (95.7 g), respectively. A portion
(10.0 g) of EMeOH was suspended in water and extracted
with ethyl acetate (EtOAc) to produce the EtOAc (4.5 g)
and aqueous (4.1 g) fractions.
The EtOAc fraction (4.0 g) was submitted to Gel
Permeation Chromatography (GPC) on a Sephadex LH-
20 (Pharmacia) column (100 x 5 cm) was eluted with
MeOH. Fractions (8 mL) were collected and checked by
Thin Layer Chromatography (TLC) on silica gel plates
eluted with a mixture of CHCl3/MeOH/H2O (80:18:2, v/v)
and revealed either with NP/PEG reagent or with
anisaldehyde/sulfuric acid solution (Wagner et al., 1984).
Fractions 43-47 (336 mg) were purified by repeated on
column chromatography (CC) with silica gel (Merck) eluted
with CHCl3/MeOH (75:25, v/v) furnishing methyl gallate
(1) (70.0 mg) and epigallocatechin gallate (2) (3.4 mg).
Fractions 82-85 (135.0 mg) were purified by the same
procedure, yielding quercetin (3) (5.0 mg). Fractions 78-
81 (140.0 mg) were purified by HPLC, using MeOH/H2O
(45:55, v/v) as eluent, yielding quercetin-3-O-(2”-galloyl)-
a-L-arabinopyranoside (4) (12.0 mg). Their structures were
characterized mainly by 1H NMR, 13C NMR, COSY and
TOCSY experiments.
The NMR spectra were obtained in DMSO-d6
solution, using a Varian INOVA 500 spectrometer,
operating at 500 MHz for 1H and 150 MHz for 13C.
Chemical shifts are given as d (ppm) using TMS as an
internal standard. TLC analyses were performed on silica
gel Si F254 (Merck) plates eluted with CHCl3/MeOH
(80:20, v/v). The plates were visualized using UV light
(254 and 365 nm).
Disc diffusion method:The dried plant extracts were
dissolved in DMSO to a final concentration of 30 mg/mL
and sterilized by filtration through 0.45 mm Millipore
filters. Antimicrobial tests were carried out by the disc
diffusion method (Bauer et al., 1966).
All the microorganism inoculum cultures were
grown in Brain Heart Infusion liquid medium at 37 ºC.
After 6 h of growth, 100mL of inoculum, at a concentration
of 106 cells/mL, was spread on the surface of Mueller-
Hinton agar plates. After drying, filter paper discs (6 mm
in diameter) saturated with extracts (20 mL) were placed
on surface of each inoculated plate. The plates were
incubated at 35 ºC for 24 h for bacteria and for 48 h for C.
albicans. After this period, the zones of growth inhibition
around the discs were measured. Overall, cultured
microorganisms with diameter of inhibition zone equal to
or greater than 7 mm (Nascimento et al., 2000) were
considered susceptible to the tested extract. DMSO was
used to dissolve the extracts.
The negative control was the solvent used and the
positive control was ciprofloxacin (5 mg/disc) for bacteria
and ketoconazole (40 mg/disc) for C. albicans. All
determinations were made in duplicate.
Minimum inhibitory concentration:The minimum
inhibitory concentration (MIC) was determined by the
dilution method, as specified by the National Committee
for Clinical Laboratory Standards (NCCLS, 2003). The
bacteria were grown in nutrient broth (5 mL) for 6 h at 37
°C. After the incubation, 20 mL of this culture at 106 cells/
mL were inoculated into tubes of nutrient broth
supplemented with different volumes (25-800 mL) of
the extracts of 30 mg/mL. After 24 h at 37 ºC, the MIC
of each sample was found by measuring of the optical
density (OD) in a spectrophotometer (620 nm) and
comparing the sample OD with that of sterile nutrient
broth (Nascimento et al., 2000). All determinations were
made in duplicate.
RESULTS
A total of eight microorganisms, 7 bacteria and one
yeast, were tested.
The preliminary biological screening indicated
that EMeOH and EMeOH 80%, including both the
EtOAc and aqueous fractions of EMeOH, showed
antimicrobial activity against  Staphylococcus
epidermidis, Bacillus cereus, B. subtilis, Salmonella sp.,
Proteus mirabilis, Enterococcus faecalis,  Shigella sp.
and Candida albicans.
The results of the antimicrobial activity test, shown
in Table 1, revealed that the growth of all microorganisms
evaluated were affected by all the extracts and fractions by
forming clear inhibition zones between 8 to 14 mm of
diameter. The blind control (dimethyl sulphoxide) did not
inhibit any of the microorganisms tested. MIC values of
1.5-12 mg/mL were obtained for the extracts and fractions
in the tests (Table 2).
The chemical profiles of EtOAc and aqueous
fractions of EMeOH were evaluated by TLC analysis. Plates
revealed with NP/PEG reagent produced intense orange
and yellow spots characteristic of flavonoids and plates
revealed with anisaldehyde/sulfuric acid solution also
produced reddish spots, suggesting the presence of catechin
derivatives (Wagner et al., 1984). The EtOAc fraction
showed the presence of flavonoids. The aqueous fraction
showed exclusively tannins.
Since the EMeOH showed antimicrobial activity,
we performed a phytochemical investigation on this
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Dose (mg/mL) S.e. B.c. B.s. Sal. P.m. E.f. Shi. C.a. 
EMeOH 
50 11 9 9 11 9 12 10 11 
75 12 10 10 11 10 12 11 11 
100 12 11 11 12 10 13 11 13 
EMeOH 80% 
50 10 11 10 10 10 12 9 12 
75 11 12 10 10 11 12 10 14 
100 11 12 10 11 11 13 10 14 
EtOAc  fraction 
50 10 10 9 11 10 10 9 11 
75 11 10 9 11 10 10 10 11 
100 11 11 9 11 10 11 11 12 
Aqueous fraction  
50 8 8 8 9 9 9 9 10 
75 9 9 8 9 9 10 10 10 
100 11 9 8 9 9 10 10 10 
Ciprofloxacin 25 20 20 22 22 22 22 NT 
Ketoconazole NT NT NT NT NT NT NT 16 
 
Table 1 - Antimicrobial activities of EMeOH, EMeOH 80% and fractions of Byrsonima crassa,
ciprofloxacin and ketoconazole.
Diameter of zone (mm), S.e., Staphylococcus epidermidis, B.c., Bacillus cereus, B.s., Bacillus subtilis, Sal., Salmonella, P.m., Proteus
mirabilis, E.f., Enterococcus faecalis, Shi., Shigella, C.a., Candida albicans, NT, not tested.
Extract (mg/mL) S.e. B.c. B.s. Sal. P.m. E.f. Shi. C.a. 
EMeOH 1.5 6.0 6.0 9.0 12.0 6.0 3.0 3.0 
EMeOH 80% 9.0 6.0 9.0 6.0 7.5 7.5 7.5 3.0 
EtOAc  fraction 6.0 3.0 6.0 7.5 9.0 6.0 3.0 7.5 
Aqueous fraction 7.5 6.0 6.0 6.0 9.0 6.0 7.5 6.0 
 S.e., Staphylococcus epidermidis, B.c., Bacillus cereus, B.s., Bacillus subtilis, Sal., Salmonella sp., P.m., Proteus mirabilis, E.f.,
Enterococcus faecalis, Shi., Shigella sp., C.a., Candida albicans.
Table 2 -  Minimum inhibitory concentration (MIC) exhibited by Byrsonima crassa extracts.
exctract. Fractionation of an aliquot of the EtOAc fraction
from the EMeOH by GPC followed by purification by
several chromatographic procedures led to the isolation of
methyl gallate (1), quercetin (3), (-)-epigallocatechin gallate
(2) and quercetin-3-O-(2”-galloyl)-a-L-arabinopyranoside
(4) (Figure 1), identified by comparison of their
spectroscopic data to those reported in the literature (Binutu
& Cordell, 2000; Harborne, 1996; Agrawal, 1989).
DISCUSSION
There is a large number of plant extracts which
present antimicrobial activity.  Phyllanthus amarus extracts
possessed antibacterial activity against Bacillus subtilis,
Klebsiella pneumonia, Pseudomonas aeruginosa, Proteus
mirabilis, Salmonella paratyphi and Staphylococcus aureus
(Srinivasan et al., 2001). Extracts of Azadirachta indica,
Cinnamomum cassia, Rumex nervosus, Ruta graveolens,
Thymus serpyllum and Zingiber officinale were active
against Bacillus cereus, with MIC of 0.16 to 0.66 mg/mL
(Alzoreky & Nakahara, 2003). Hamamelis virginiana
showed antimicrobial activity on Morganella morganii with
OCH3O
OH
OH
HO
O
OOH
HO
OH
OH
OR
R=H, 3 
R=(2"-galloyl)-α-L-arabinopyranoside, 4 
1 2
O
O
O
OH
OH
OH
OH
OH
OH
HO
FIGURE 1 - Compounds isolated from the EMeOH of B.
crassa leaves
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MIC 180 µg/mL and the equal values of H. virginiana on
S. aureus 105 µg/mL (Djipa et al., 2000). Martínez-Vasquez
et al. (1999) had described the antimicrobial activity of B.
crassifolia. In this study, we report the antibacterial activity
of B. crassa leaf extracts. The EMeOH, EMeOH 80%,
EtOAc and aqueous fractions were active, showing
antibacterial activity against all the tested bacteria and
antifungal activity against the yeast (Tables 1 and 2). MIC
values are between 1.5 and 12 mg/mL, which are similar
to those of plants extracts found in the literature. In some
cases we observed that when the disc dosage level increases,
the inhibitory effect also increased (Table 1).
Previously, we have reported the isolation of
amentoflavone, quercetin-3-O-b-D-galactopyranoside,
quercetin-3-O-a-L-arabinopyranoside, (+)-catechin and (-
)-epicatechin from the B. crassa leaves (Sannomiya et al.,
2004; 2005). Here we are adding the isolation of the minor
compounds 1 – 4 of the EtOAc fraction from the EMeOH
(Figure 1). In fact, Penna et al. (2001) reported the
antimicrobial activity of methyl gallate against
Staphylococcus aureus with MIC 128 mg/mL. Quercetin
showed antibacterial activity against Staphylococcus
aureus, Proteus vulgaris, Klebsiella pneumoniae,
Enterobacter cloacae, Pseudomonas aeruginosa,
Escherichia coli, Salmonella typhi and Enterobacter
aerogens (Basile et al., 2000). Epicatechin and quercetin-
3-O-b-D-galactopyranoside were active in the inhibition
the growth of Moraxella catarrhalis, Streptococcus
pneumoniae and Haemophilus influenza (Pretorius et al.,
2003). Thus, the isolated compounds can account to the
antibacterial activity B. crassa leaves.
Further phytochemical studies are required to
establish whelther these compounds are responsible for the
bioactivity of this medicinal plant and evaluate the
ethnobotanical approach for the screening of plants as
potential sources of bioactive substances (Lopez et al.,
2001). However, the aforementioned results may suggest
that B. crassa possess compounds with antibacterial and
antifungal properties which can be used as antimicrobial
agents in new drugs for therapy of infectious diseases.
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